and so did Oncovista. Genzyme is getting bought for $20 billion by Sanofi-Aventis. Genzyme bought Ilex Oncology in 2004 for $1 billion dollars to cement their way into that segment. The co-founder/CSO of Ilex Oncology's current company now has a market cap of $10 million dollars, I think OVIT will be the best biotech in 2011.
If you made money betting on the Biomarin CEO in Raptor, you should look at betting on the Ilex co-founder Alex Weis in ticker OVIT.